omega-n-methylarginine has been researched along with pervanadate in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (pervanadate) | Trials (pervanadate) | Recent Studies (post-2010) (pervanadate) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 367 | 1 | 29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolander, FF | 1 |
1 other study(ies) available for omega-n-methylarginine and pervanadate
| Article | Year |
|---|---|
Transduction pathways involved in rapid hormone receptor regulation in the mammary epithelium.
Topics: Androstadienes; Animals; Calcimycin; Cell Membrane; Cyclic GMP; Down-Regulation; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Female; Gene Products, env; Genistein; Mammary Glands, Animal; Mammary Tumor Virus, Mouse; Mice; Mice, Inbred C3H; Models, Biological; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Organ Culture Techniques; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Receptors, Prolactin; Signal Transduction; Up-Regulation; Vanadates; Wortmannin | 1998 |